226 related articles for article (PubMed ID: 35832545)
21. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Detection of Charged
Samal J; Palomino TV; Chen J; Muddiman DC; Segura T
Anal Chem; 2023 Jul; 95(29):10913-10920. PubMed ID: 37427925
[No Abstract] [Full Text] [Related]
23. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
25. N-glycan profiling of papillary thyroid carcinoma tissues by MALDI-TOF-MS.
Koçak ÖF; Kayili HM; Albayrak M; Yaman ME; Kadıoğlu Y; Salih B
Anal Biochem; 2019 Nov; 584():113389. PubMed ID: 31400301
[TBL] [Abstract][Full Text] [Related]
26. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
27. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
28. Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDI mass spectrometry.
Toghi Eshghi S; Yang S; Wang X; Shah P; Li X; Zhang H
ACS Chem Biol; 2014 Sep; 9(9):2149-56. PubMed ID: 25029481
[TBL] [Abstract][Full Text] [Related]
29. Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.
Reiding KR; Ruhaak LR; Uh HW; El Bouhaddani S; van den Akker EB; Plomp R; McDonnell LA; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; Wuhrer M
Mol Cell Proteomics; 2017 Feb; 16(2):228-242. PubMed ID: 27932526
[TBL] [Abstract][Full Text] [Related]
30. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
[TBL] [Abstract][Full Text] [Related]
31. Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells.
Guo J; Liu C; Zhou X; Xu X; Deng L; Li X; Guan F
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763000
[TBL] [Abstract][Full Text] [Related]
32. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
33. Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Ballinger TJ; Jiang G; Shen F; Miller KD; Sledge GW; Schneider BP
Cancer; 2022 Jun; 128(11):2174-2181. PubMed ID: 35285940
[TBL] [Abstract][Full Text] [Related]
34. Affluence and Breast Cancer.
Lehrer S; Green S; Rosenzweig KE
Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
[TBL] [Abstract][Full Text] [Related]
35. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
36. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
[TBL] [Abstract][Full Text] [Related]
37. Negative Ion-Mode N-Glycan Mass Spectrometry Imaging by MALDI-2-TOF-MS.
Soltwisch J; Heijs B
Methods Mol Biol; 2023; 2688():173-186. PubMed ID: 37410293
[TBL] [Abstract][Full Text] [Related]
38. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes.
DelaCourt A; Black A; Angel P; Drake R; Hoshida Y; Singal A; Lewin D; Taouli B; Lewis S; Schwarz M; Fiel MI; Mehta AS
Mol Cancer Res; 2021 Nov; 19(11):1868-1877. PubMed ID: 34380744
[TBL] [Abstract][Full Text] [Related]
39. Applications and continued evolution of glycan imaging mass spectrometry.
McDowell CT; Lu X; Mehta AS; Angel PM; Drake RR
Mass Spectrom Rev; 2023 Mar; 42(2):674-705. PubMed ID: 34392557
[TBL] [Abstract][Full Text] [Related]
40. Core-Fucosylated Tetra-Antennary
Herrera H; Dilday T; Uber A; Scott D; Zambrano JN; Wang M; Angel PM; Mehta AS; Drake RR; Hill EG; Yeh ES
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
